Ironshore Pharmaceuticals Inc.
$1.3M 45,495 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Spinal Elements, Inc.
Spinal Elements, Inc. reported $1,329,617.26 across General Payments, Research, and Ownership to 850 physicians and teaching hospitals across 1,032 transactions.
- $1.3M Above-median payer
- All-tracks total
- 1,032 Above-median volume
- Transactions
- 850 Above-median reach
- Recipients
- +$8.1K
- General Payments vs PY2023
Spinal Elements, Inc. reported $1,329,617.26 across all CMS Open Payments tracks (General + Research + Ownership) to 850 physicians and teaching hospitals in Program Year 2024 - ranking #554 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $50,591.31, averaging $1.6K per recipient.
How Spinal Elements, Inc.'s $1.3M all-tracks total breaks down
Spinal Elements, Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
23/100
Total payments
F
22/100
Transaction volume
F
17/100
Physician reach
F
16/100
Payment type diversity
F
37/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer spinal-elements-inc Spinal Elements, Inc.
$1.3M · #554/1,925 · 0.0% industry · PY2024
- TOT $1.3M
- RANK #554
- SHARE 0.0%
- TXN 1,032
- RCP 850
- CAT 3
- GEN $50.6K
- ΔGEN +$8.1K
- TOP1 3.7%
- PY 2024
Volume peers
Nearest volume peer: Ironshore Pharmaceuticals Inc. ($1.3M)
Spinal Elements, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Spinal Elements, Inc.'s CMS-reported General Payments increased by $8.1K (+19.0%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: SPINAL ELEMENTS, INC.PY2023: SPINAL ELEMENTS, INC.PY2024: SPINAL ELEMENTS, INC.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $42,516.07
- PY2024
- $50,591.31
What the Data Shows for Spinal Elements, Inc.
Three separate CMS disclosure tracks feed the all-tracks total above - General, Research, and Ownership/Investment - each reported under its own rules and combined here for one comparable figure. For Spinal Elements, Inc., that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. CMS releases each Program Year roughly 12 months after it ends; the methodology page covers the full standardization basis.
Of the 3 general-payment categories charted below, "Food and Beverage" is the largest at $48.6K across 806 transactions, 96.1% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
Across 3 types of general payments, Spinal Elements, Inc.'s largest category was "Food and Beverage" at $48.6K - 96.1% of General Payments.
How Spinal Elements, Inc. divides its payments
Top payment categories by total reported dollar volume
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Food and Beverage | $48.6K | 806 | 96.1% |
| Entertainment | $1.8K | 40 | 3.5% |
| Travel and Lodging | $193.84 | 4 | 0.4% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $6,192.10 (12.2%) of $50,591.31 in this company's General Payments records across 412 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Spinal Elements, Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Neel Anand
$1,866.23 across 25 reported transactions
- 2
Simon a Salerno
$1,176.43 across 16 reported transactions
- 3
Ryan Michael Johnson
$1,098.09 across 16 reported transactions
- 4
Jeffrey Todd Smith
$1,058.55 across 18 reported transactions
- 5
Ernest Earl Braxton
$992.80 across 10 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Spinal Elements, Inc. ranks #554 of 1,925 by total payments (top 29% by spend) but spreads that money notably more broadly than its spend rank alone would suggest -- #1,716 of 1,838 by HHI (bottom 7% least concentrated), a wider distribution than most similarly sized payers.
View all 12 companies in this HHI neighborhood as a list
- Sight Sciences, Inc. : $1.0M total payments, HHI 85
- Astellas Pharma US Inc : $10.6M total payments, HHI 85
- Centrix Inc : $17.9K total payments, HHI 84
- Endologix LLC : $725.4K total payments, HHI 84
- Novartis Pharmaceuticals Corporation : $19.7M total payments, HHI 84
- Seapearl East, Inc : $93.9K total payments, HHI 83
- Spinal Elements, Inc. (this company) : $50.6K total payments, HHI 83
- Tris Pharma Inc : $742.6K total payments, HHI 83
- Aquestive Therapeutics, Inc. : $5.5K total payments, HHI 81
- Notal Vision, Inc. : $13.1K total payments, HHI 81
- Atricure, Inc. : $4.9M total payments, HHI 80
- Ipsen Biopharmaceuticals, Inc : $4.5M total payments, HHI 79
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Spinal Elements, Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Spinal Elements, Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Spinal Elements, Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Mayne Pharma Commercial LLC
$1.3M 29,072 recipients
Compare payment profiles
Sight Sciences, Inc.
$1.3M 7,583 recipients
Compare payment profiles
C. R. Bard, Inc. & Subsidiaries
$1.3M 2,216 recipients
Compare payment profiles
Surmodics, Inc.
$1.3M 2,433 recipients
Compare payment profiles
Leadiant Biosciences, Inc.
$1.3M 65 recipients
Compare payment profiles
Put this to use
Spinal Elements, Inc. ranks #554 of 1,925 by all-tracks total payments, led by "Food and Beverage".
- See where Spinal Elements, Inc. sits among every top spender on the full leaderboard. Top 100 by total payments
- Compare "Food and Beverage" spend across every manufacturer, not just Spinal Elements, Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.